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Synergy between 
norepinephrine and 
angiotensin II
The control of glomerular hemodynam-
ics often focuses on the efferent arteriole, 
the target of angiotensin II. But the affer-
ent arteriole also plays a role. Several 
agents constrict this arteriole, albeit at 
concentrations that are supraphysiologi-
cal. In new findings presented in this 
issue, Lai et al. showed that norepine-
phrine potentiated the vasoconstrictor 
effect of low doses of angiotensin II to 
constrict the vessels in isolated affer-
ent arterioles. The mechanism by which 
this synergy occurred appeared to be 
due to the effect of norepinephrine on 
increasing phosphorylation of myosin 
light chain. These studies suggest that 
the calcium sensitivity of the smooth 
muscle is enhanced by norepinephrine, 
allowing angiotensin II to cause contrac-
tion at lower concentrations. Since many 
clinical situations of prerenal azotemia 
are associated with increased levels of 
both hormones, this synergy must play 
a significant role in the reduction of 
glomerular filtration rate often seen in 
such conditions. See page 953.
Vitamin D levels  
and mortality  
in renal disease
While the classic action of vitamin D 
in bone metabolism is well established, 
evidence is increasing for its involve-
ment in other target tissues. Epide-
miological studies have suggested that 
low vitamin D levels predict higher 
cardiovascular risk. Mehrotra et al. 
reasoned that many patients with end-
stage renal disease have low levels 
of vitamin D and hence studied the 
relationship between low levels of the 
vitamin and death. Using a cohort of 
the National Health and Nutrition 
Examination Survey—patients who had 
chronic kidney disease but were not on 
dialysis—the authors found that 9 years 
later, patients with low vitamin D lev-
els had an increased risk for all-cause 
mortality, even when corrected for all 
known confounding factors. Further, 
the relationship as a function of serum 
vitamin D concentration revealed a 
graded response whereby patients 
with levels of vitamin D below 15 ng/
ml were at risk for mortality whereas 
those with higher levels were not. 
Whether this epidemiological finding 
mandates treatment in kidney disease 
patients will have to await the results 
of a large, randomized, controlled trial. 
See page 977.
Risk of death 
with nocturnal 
hemodialysis
Nocturnal hemodialysis is a new modality 
of dialysis that needs to be compared with 
traditional thrice-weekly hemodialysis. 
Johansen et al. estimated the survival and 
hospitalization rates in a cohort of patients 
undergoing nocturnal hemodialysis and 
compared them with those in similar 
cohorts undergoing traditional hemodi-
alysis and short-duration daily hemodialy-
sis. Careful attention was paid to studying 
patients with similar histories and comor-
bidities. The authors found that patients 
undergoing nocturnal hemodialysis had 
lower rates of mortality or major morbid 
events when compared with those on con-
ventional hemodialysis. Patients with the 
short-duration daily hemodialysis also had 
a reduced risk of death, but the reduction 
was not statistically significant. This study 
suggests that nocturnal hemodialysis may 
improve patient survival. See page 984.
It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
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